Fulgent Genetics Inc.

50.10-2.62-4.97%Vol 601.28K1Y Perf -51.97%
Aug 9th, 2022 16:00 DELAYED
BID50.00 ASK51.83
Open52.23 Previous Close52.72
Pre-Market- After-Market50.56
 - -  0.46 0.92%
Target Price
70.00 
Analyst Rating
Strong Buy 1.00
Potential %
39.72 
Finscreener Ranking
★★★★★     68.24
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★★     71.72
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     84.76
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
4.27 
Earnings Rating
Strong Sell
Market Cap1.52B 
Earnings Date
4th Aug 2022
Alpha0.05 Standard Deviation0.25
Beta1.51 

Today's Price Range

50.0153.93

52W Range

47.34112.00

5 Year PE Ratio Range

-670.0021.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-12.13%
1 Month
-10.45%
3 Months
4.09%
6 Months
-26.16%
1 Year
-51.97%
3 Years
366.14%
5 Years
834.75%
10 Years
-

TickerPriceChg.Chg.%
FLGT50.10-2.6200-4.97
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
77.00
64.10
65.50
18.50
47.63
RevenueValueIndustryS&P 500US Markets
799.81M
26.37
257.33
134.94
Earnings HistoryEstimateReportedSurprise %
Q02 20220.590.590.00
Q01 20224.324.9314.12
Q04 20212.663.3425.56
Q03 20211.303.93202.31
Q02 20212.542.47-2.76
Q01 20215.956.519.41
Q04 20204.366.1240.37
Q03 20200.391.95400.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.59-43.27Negative
9/2022 QR0.18-79.55Negative
12/2022 FY5.71-21.78Negative
12/2023 FY-0.43-115.87Negative
Next Report Date-
Estimated EPS Next Report0.59
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume601.28K
Shares Outstanding30.27K
Shares Float18.00M
Trades Count13.04K
Dollar Volume31.44M
Avg. Volume338.60K
Avg. Weekly Volume406.20K
Avg. Monthly Volume281.29K
Avg. Quarterly Volume328.31K

Fulgent Genetics Inc. (NASDAQ: FLGT) stock closed at 52.72 per share at the end of the most recent trading day (a -11.93% change compared to the prior day closing price) with a volume of 701.31K shares and market capitalization of 1.52B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 139 people. Fulgent Genetics Inc. CEO is Ming Hsieh.

The one-year performance of Fulgent Genetics Inc. stock is -51.97%, while year-to-date (YTD) performance is -47.59%. FLGT stock has a five-year performance of 834.75%. Its 52-week range is between 47.34 and 112, which gives FLGT stock a 52-week price range ratio of 4.27%

Fulgent Genetics Inc. currently has a PE ratio of 3.90, a price-to-book (PB) ratio of 1.36, a price-to-sale (PS) ratio of 2.17, a price to cashflow ratio of 3.70, a PEG ratio of 2.32, a ROA of 38.24%, a ROC of 42.90% and a ROE of 44.66%. The company’s profit margin is 47.63%, its EBITDA margin is 65.50%, and its revenue ttm is $799.81 Million , which makes it $26.37 revenue per share.

Of the last four earnings reports from Fulgent Genetics Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.59 for the next earnings report. Fulgent Genetics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fulgent Genetics Inc. is Strong Buy (1), with a target price of $70, which is +39.72% compared to the current price. The earnings rating for Fulgent Genetics Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fulgent Genetics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fulgent Genetics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 17.83, ATR14 : 2.93, CCI20 : -183.27, Chaikin Money Flow : -0.05, MACD : 0.76, Money Flow Index : 52.56, ROC : -12.57, RSI : 30.80, STOCH (14,3) : 0.88, STOCH RSI : 0.00, UO : 40.82, Williams %R : -99.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fulgent Genetics Inc. in the last 12-months were: Han Lin Gao (Sold 950 shares of value $76 919 ), Jian Xie (Sold 32 508 shares of value $2 152 264 ), John C. Bolger (Option Excercise at a value of $13 519), John C. Bolger (Sold 1 750 shares of value $111 799 ), Paul Kim (Sold 17 401 shares of value $1 568 454 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to a disease and enhanced disease treatment and prognosis.

CEO: Ming Hsieh

Telephone: +1 626 350-0537

Address: 4978 Santa Anita Avenue, Temple City 91780, CA, US

Number of employees: 139

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

59%41%

Bearish Bullish

55%45%


News

Stocktwits